Milk thistle safety: side effects, interactions and who should avoid it

How well tolerated is milk thistle?

Milk thistle's safety record is reassuring, though narrower than its reputation suggests. A 2019 safety review found silymarin, the extract's active complex, generally well tolerated in people, including at 2,100 mg/day (700 mg three times daily) for 24 weeks. Gastrointestinal upset was what limited higher doses.

That 24-week figure is the upper edge of what has been tested, not a typical trial. Many of the studies behind it ran far shorter. A 2-year trial in 200 people with alcoholic cirrhosis used 450 mg/day, but the findings we have on it concern whether it changed survival (it did not), not long-term safety.

So "generally well tolerated" is a fair summary of the evidence. "Proven safe for years" is not. For background on what the extract is and what it has been studied for, see our milk thistle overview.

It also helps to remember who took part. The longest and most detailed trials were run in people with diagnosed conditions, under medical supervision. That is a different situation from a healthy adult adding a capsule to a morning routine.

Common side effects

The documented side effects are mostly mild. An NIH reference monograph lists these as the most commonly reported in adults:

• Diarrhea. The most frequently mentioned effect, and one that rose with dose in the safety review.
• Nausea. Also dose-related, and the other main reason higher doses were hard to tolerate.
• Headache. Reported in some adults at ordinary doses.
• Skin reactions. Itching would most plausibly fall here.

Gas, bloating, heartburn and dizziness are not named in the safety sources we reviewed. That is a gap in reporting, not proof they never happen, and mild digestive symptoms could sit under the broader "gastrointestinal upset" label. Hair loss and bleeding are not described as milk thistle effects in any of them.

Milk thistle is not a laxative. Loose stools show up in the data as an unwanted effect that gets more likely at higher doses. If it persists, stop the supplement and check in with a clinician instead of pushing through.

The ragweed-family allergy problem

The most important exclusion is botanical. Milk thistle belongs to the Asteraceae (Compositae) family, alongside ragweed, daisies, artichokes, common thistle and kiwi. An NIH drug and lactation database flags people allergic to any of these as being at higher risk of a cross-reaction.

Severe reactions, including anaphylaxis, are rare. They are also the one risk that does not scale with dose in the way stomach upset does. If you have a known allergy to ragweed or a related plant, the database's advice is to avoid milk thistle. Our own guide on who should not take milk thistle covers the same ground in more detail.

Drug interactions: small evidence, one clear signal

Reviews describe milk thistle's overall interaction potential as low. They also recommend caution with drugs that have a narrow safe-dose range, where small changes in blood levels matter. The underlying human studies are few, small, and not entirely in agreement.

• Losartan. In a 2009 crossover trial, 12 healthy men took 420 mg/day of silymarin for 14 days. In those with the common CYP2C91/1 genotype, losartan blood levels rose significantly; in those with 1/3, they did not. Levels of losartan's active breakdown product fell in both groups.
• Four major liver enzymes. A 2014 study gave 9 healthy volunteers a standardized extract three times daily for 14 days and found no significant effect on CYP1A2, CYP2C9, CYP2D6 or CYP3A4/5. That includes CYP2C9, the enzyme implicated in the losartan result.
• Warfarin. The often-repeated claim that milk thistle affects warfarin through CYP3A4 is not confirmed by the human data we reviewed. Nor does any trial show it acting as a blood thinner.
• Metformin, thyroid medication, birth control. We found no human trial testing milk thistle with any of these. Absence of data is not reassurance.
• Chemotherapy and iron chelators. Silymarin has been studied as an add-on in small, supervised trials: 30 breast cancer patients, 70 colorectal cancer patients, and a pooled analysis in thalassemia patients taking chelation drugs. Those were medically directed, and none is a reason to add it on your own.

The honest reading is that an interaction is real in at least one documented case and not predictable in general. If you take a prescription drug, especially a blood-pressure medication such as losartan, tell your prescriber or pharmacist first. Our page on milk thistle and medications walks through the same studies.

Stacking supplements and absorption-boosted formulas

Plain silymarin is poorly absorbed. A 2021 systematic review attributes this largely to the body processing and excreting its compounds before much reaches the bloodstream. That is why makers add enhancers, and why the safety picture can shift with the formula.

A 2005 review found that binding silybin to phosphatidylcholine, as a phytosome, improved absorption compared with plain extract. In a 2019 rat study, piperine from black pepper raised silybin's bioavailability by 146–181%. That was an animal and cell-line result, not a human trial. The human safety data summarized above do not address these enhanced products, so treat them as a potentially higher exposure.

Stacking deserves similar care. Milk thistle is often paired with other supplements for "liver support," but nothing in the studies we reviewed shows it offsetting another ingredient's risks. A 2026 review of ashwagandha documented reports of liver toxicity with prolonged or high-dose use, and a case report described acute-on-chronic liver failure in a person with a preexisting liver condition. NAC, by contrast, is generally considered safe, though trial results for its many supplement uses are mixed.

The practical rule: change one thing at a time, keep a list of everything you take, and show it to whoever manages your prescriptions.

Who should check first, or avoid it

On the liver, the evidence cuts both ways. We found no clinical evidence of milk thistle damaging the liver at trial doses. But those trials enrolled people who already had liver conditions and were monitored by doctors, so they say little about unsupervised use.

Nor is it established as a treatment. A pooled analysis of six trials found ALT and AST fell by a statistically significant but clinically negligible amount. A trial of up to 2,100 mg/day in 154 people with hepatitis C showed no benefit over placebo. The cirrhosis trial found no effect on survival.

For kidneys, a small trial of 420 mg/day for 3 months in diabetic kidney disease lowered a urine-protein marker. A larger trial found no difference in kidney function decline, dialysis or death, though hospitalizations were lower. If you have a kidney diagnosis, that is a conversation for your nephrologist.

Warning signs: when to stop

Less urgent signals still justify stopping and checking in:

• Diarrhea or nausea that does not settle.
• A new rash or persistent itching.
• Any unexpected change in how a prescription drug is working. Mention milk thistle to your prescriber, especially if you take losartan.
• Yellowing of the skin or eyes, dark urine or marked fatigue. These are general signs of liver trouble, not documented milk thistle effects, but they matter most if you combine several supplements.

Milk thistle is not a substitute for medical care or a prescribed medication, and no dose or timing change for a drug should be made without medical guidance.